Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NIDA
Recent news which mentions NIDA
Fed Health Official: Cannabis Industry Borrowing Marketing Tactics From Tobacco, Alcohol Industries
October 02, 2024
Tickers
NEWS
Tags
Tobacco Industry
seniors and cannabis
National Institute on Drug Abuse
From
Benzinga
Federal Drug Official: Treating Drug Addiction With Incarceration Is Ineffective And 'Dangerous,' Calls For Overhaul
July 16, 2024
Tags
National Institute on Drug Abuse
Cannabis
Markets
From
Benzinga
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
May 29, 2024
Tickers
NEWS
Tags
Ketamine
PTSD
NIDA
From
Benzinga
Ozempic, Wegovy Lowers Risk Of Cannabis Use Disorder Says New Study
March 21, 2024
Tickers
NEWS
Tags
Top Stories
Ozempic
NIDA
From
Benzinga
Canadian Teens Find Cannabis Harder To Get Post-Legalization, Study Finds
December 28, 2023
Tickers
CDC
Tags
Regulations
Market News
Cannabis
From
Benzinga
The Kids Are Alright: Government Study Finds Teen Cannabis Use Holds Steady Despite Increased State Legalization
December 13, 2023
Tags
Teens cannabis use
Benzinga
Cannabis
From
Benzinga
Canada Vs. US: Surveys Reveal How People Use Psychedelics, Relationships With Healthcare Providers
August 23, 2023
Tags
NIDA
Psychedelic/Assisted Therapies
Benzinga
From
Benzinga
Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds
August 17, 2023
Tags
Benzinga
Cannabis
Market News
From
Benzinga
Study Reveals Groundbreaking Treatment For Cannabis Use Disorder With A New Class Of Medication
June 09, 2023
Tags
Cannabis
AEF0117
Pier Vincenzo Piazza
From
Benzinga
Why Are Cannabis Users Often Lean Despite The Munchies? Science May Have The Answer
June 02, 2023
Tags
cannabis study
News
Daniele Piomelli
From
Benzinga
Federal Psychedelics Reform Has More Lobbyists, Addiction Research Grant & Upcoming $27M VA Report
May 31, 2023
Tags
Psychedelic/Assisted Therapies
NIDA
Veterans Psychedelics
From
Benzinga
NIDA Director Nora Volkow Calls Regulating Cannabis 'Crucial' As More States Legalize It
May 19, 2023
Tags
Regulations
News
Government
From
Benzinga
NIDA Partners With The National Institute Of Mental Health To Study Psychedelics Potential
May 05, 2023
Tags
General
Government
Psychedelics Research
From
Benzinga
NIDA Study Finds Young Men At Higher Risk Of Schizophrenia Linked With Cannabis Use Disorder
May 04, 2023
Tags
cannabis dependency
NIDA
Markets
From
Benzinga
Top FDA Official Says Marijuana Scheduling Review Is 'A Very High Priority,' But Who Has Final Say?
October 28, 2022
Tickers
HHS
Tags
medical marijuana
FDA
Benzinga
From
Benzinga
More Adults, Fewer Teens, Are Using Psychedelics, Columbia University Study Finds
August 28, 2022
Tags
NIDA
Benzinga
Market News
From
Benzinga
NIDA Director Dr. Nora Volkow Calls For 'Urgent' Research Into Risks Of Regular Cannabis Use, Citing Effects On Brain Development
August 24, 2022
Tags
cannabis use and risks
cannabis and IQ
cannabis and brain development
From
Benzinga
Psychedelics And The National Institutes Of Health—How Do They Relate?
July 26, 2022
Tags
Cannabis
Financing
Market News
From
Benzinga
National Institute On Drug Abuse Seeks To Set Up Medical Marijuana Registry, Here's How It Will Function
June 16, 2022
Tickers
CBD
Tags
Markets
NIDA
News
From
Benzinga
New Study Finds Marijuana Research Has Increased Despite Prohibition
May 31, 2022
Tags
Benzinga
Journal Of Cannabis Research
NIDA
From
Benzinga
What 2021 Taught Us About Youth Cannabis Use
January 04, 2022
Tickers
CDC
Tags
Survey
Benzinga
Market News
From
Benzinga
Study: Marijuana Use Among College-Age Adults Hit Historic High In 2020, Alcohol Use Declines
September 08, 2021
Tags
NIDA
Education
Benzinga
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.